Cargando…

37606 Enhanced radiation therapy using chlorin-e6 conjugated gold nanoparticles

ABSTRACT IMPACT: Improved radiation treatment will yield higher doses at the tumor site, while reducing damage to healthy tissue, which will improve clinical outcomes. OBJECTIVES/GOALS: Development of gold nanoparticles covalently linked to a photosensitizer for use to enhance radiation therapy. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenkins, Samir V., Griffin, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827826/
http://dx.doi.org/10.1017/cts.2021.513
_version_ 1784647722849009664
author Jenkins, Samir V.
Griffin, Robert J.
author_facet Jenkins, Samir V.
Griffin, Robert J.
author_sort Jenkins, Samir V.
collection PubMed
description ABSTRACT IMPACT: Improved radiation treatment will yield higher doses at the tumor site, while reducing damage to healthy tissue, which will improve clinical outcomes. OBJECTIVES/GOALS: Development of gold nanoparticles covalently linked to a photosensitizer for use to enhance radiation therapy. The particles will be thoroughly characterized and the mechanism uncovered. The efficacy of these particles will be tested in a murine system. METHODS/STUDY POPULATION: Gold nanoparticles were synthesized and coated with amine-terminated poly(ethylene) glycol then covalently conjugated to chlorin e6, a known, FDA approved photosensitizer. The system was characterized using UV-Vis spectroscopy, transmission electron microscopy, and nanoparticle tracking analysis. The generation of reactive oxygen species following X-irradiation was measured. Enhanced cell killing was measured clonogenically and in vivo efficacy and tumor pathology was assessed in a murine system. Further studies will determine the optimum combination of particle shape, photosensitizer structure, and ratio of components, as well as the optimal dosing schedule. RESULTS/ANTICIPATED RESULTS: Conjugation of the particle to the photosensitizer was successfully achieved, and the molecule was detectable by UV-Vis spectroscopy. TEM and NTA showed no aggregation of the particles, and an increase in reactive oxygen species generation was observed. The conjugates significantly increased cell killing during radiation treatment, while neither the particle alone or the photosensitizer significantly affected clonogenic survival at the same concentrations. Pathology of breast tumors grown in immunocompetent mice showed a significant increase in necrotic tissue following a single 20 gy treatment when the conjugate was present. DISCUSSION/SIGNIFICANCE OF FINDINGS: Radiation therapy is widely used clinically and it is a highly localized form of treatment. However, the total dose of radiation is limited largely to prevent injury to adjacent normal tissue. This conjugate has the potential to increase the effective dose in the tumor thereby reducing damage to healthy tissue and providing a more effective therapy.
format Online
Article
Text
id pubmed-8827826
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-88278262022-02-28 37606 Enhanced radiation therapy using chlorin-e6 conjugated gold nanoparticles Jenkins, Samir V. Griffin, Robert J. J Clin Transl Sci Commercialization/Entrepreneurship ABSTRACT IMPACT: Improved radiation treatment will yield higher doses at the tumor site, while reducing damage to healthy tissue, which will improve clinical outcomes. OBJECTIVES/GOALS: Development of gold nanoparticles covalently linked to a photosensitizer for use to enhance radiation therapy. The particles will be thoroughly characterized and the mechanism uncovered. The efficacy of these particles will be tested in a murine system. METHODS/STUDY POPULATION: Gold nanoparticles were synthesized and coated with amine-terminated poly(ethylene) glycol then covalently conjugated to chlorin e6, a known, FDA approved photosensitizer. The system was characterized using UV-Vis spectroscopy, transmission electron microscopy, and nanoparticle tracking analysis. The generation of reactive oxygen species following X-irradiation was measured. Enhanced cell killing was measured clonogenically and in vivo efficacy and tumor pathology was assessed in a murine system. Further studies will determine the optimum combination of particle shape, photosensitizer structure, and ratio of components, as well as the optimal dosing schedule. RESULTS/ANTICIPATED RESULTS: Conjugation of the particle to the photosensitizer was successfully achieved, and the molecule was detectable by UV-Vis spectroscopy. TEM and NTA showed no aggregation of the particles, and an increase in reactive oxygen species generation was observed. The conjugates significantly increased cell killing during radiation treatment, while neither the particle alone or the photosensitizer significantly affected clonogenic survival at the same concentrations. Pathology of breast tumors grown in immunocompetent mice showed a significant increase in necrotic tissue following a single 20 gy treatment when the conjugate was present. DISCUSSION/SIGNIFICANCE OF FINDINGS: Radiation therapy is widely used clinically and it is a highly localized form of treatment. However, the total dose of radiation is limited largely to prevent injury to adjacent normal tissue. This conjugate has the potential to increase the effective dose in the tumor thereby reducing damage to healthy tissue and providing a more effective therapy. Cambridge University Press 2021-03-30 /pmc/articles/PMC8827826/ http://dx.doi.org/10.1017/cts.2021.513 Text en © The Association for Clinical and Translational Science 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commercialization/Entrepreneurship
Jenkins, Samir V.
Griffin, Robert J.
37606 Enhanced radiation therapy using chlorin-e6 conjugated gold nanoparticles
title 37606 Enhanced radiation therapy using chlorin-e6 conjugated gold nanoparticles
title_full 37606 Enhanced radiation therapy using chlorin-e6 conjugated gold nanoparticles
title_fullStr 37606 Enhanced radiation therapy using chlorin-e6 conjugated gold nanoparticles
title_full_unstemmed 37606 Enhanced radiation therapy using chlorin-e6 conjugated gold nanoparticles
title_short 37606 Enhanced radiation therapy using chlorin-e6 conjugated gold nanoparticles
title_sort 37606 enhanced radiation therapy using chlorin-e6 conjugated gold nanoparticles
topic Commercialization/Entrepreneurship
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827826/
http://dx.doi.org/10.1017/cts.2021.513
work_keys_str_mv AT jenkinssamirv 37606enhancedradiationtherapyusingchlorine6conjugatedgoldnanoparticles
AT griffinrobertj 37606enhancedradiationtherapyusingchlorine6conjugatedgoldnanoparticles